Rapid communicationInsight into glycyrrhetinic acid: The role of the hydroxyl group on liver targeting
Graphical abstract
Section snippets
Acknowledgement
We would like to thank Prof. Jian Tan of the Department of Nuclear Medicine, General Hospital, Tianjin Medical University for his help in the animal assays and discussion. This work was supported by the National Natural Science Foundation of China (No. 50873048, 51073080).
References (15)
- et al.
Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases
Bioorgan. Med. Chem.
(2010) - et al.
Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery
Int. J. Pharm.
(2008) - et al.
The synthesis of 18β-glycyrrhetinic acid derivatives which have increased antiproliferative and apoptotic effects in leukemia cells
Bioorgan. Med. Chem.
(2007) - et al.
Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system
Eur. J. Pharm. Sci.
(2003) - et al.
Specific binding of glycyrrhetinic acid to the rat liver membrane
Biochim. Biophys. Acta
(1991) - et al.
Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery
Biomaterials
(2010) - et al.
Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds
Phytother. Res.
(2008)
Cited by (47)
Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma
2021, Seminars in Cancer BiologyCitation Excerpt :However, Tian and colleagues showed that modifying the C3 hydroxyl group using nanoparticles does not affect the binding capacity of glycyrrhetinic acid for its receptor on the surface of hepatocytes. This suggests that the affinity differences may be due to the characteristics of the C3 glycosyl group in glycyrrhizin and not due to the hydroxyl group [59]. A recent study revealed that the β-configuration hydrogen atom on C18 position of glycyrrehetinic acid may have the major influence on the targeting efficacy [60].
Advanced drug delivery systems in hepatocellular carcinoma
2021, Advanced Drug Delivery Systems in the Management of CancerPaclitaxel and betulonic acid synergistically enhance antitumor efficacy by forming co-assembled nanoparticles
2020, Biochemical PharmacologySynthesis and anti-hepaticfibrosis of glycyrrhetinic acid derivatives with inhibiting COX-2
2020, Bioorganic ChemistryA conveniently synthesized Pt (IV) conjugated alginate nanoparticle with ligand self-shielded property for targeting treatment of hepatic carcinoma
2019, Nanomedicine: Nanotechnology, Biology, and Medicine